 | • レポートコード：QYR9ST03178 • 出版社/出版日：QYResearch / 2019年9月2日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥569,400 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,138,800 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、糖尿病治療薬の世界市場について調査・分析し、糖尿病治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（タイプ1、タイプ2、妊娠）、用途別（インスリン療法、非インスリン療法）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の糖尿病治療薬市場動向 ・主要企業別マーケットシェア ・糖尿病治療薬の種類別市場規模2014-2019 （タイプ1、タイプ2、妊娠） ・糖尿病治療薬の用途別市場規模2014-2019 （インスリン療法、非インスリン療法） ・糖尿病治療薬の北米市場：主要企業・種類別/用途別市場規模 ・糖尿病治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・糖尿病治療薬の中国市場：主要企業・種類別/用途別市場規模 ・糖尿病治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・糖尿病治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・糖尿病治療薬のインド市場：主要企業・種類別/用途別市場規模 ・糖尿病治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca、Eli Lilly、Merck、Novo Nordisk、Sanofi、AbbVie、Actelion Pharmaceuticals、Adocia、Aegerion Pharmaceuticals、Akros Pharma、Alnylam Pharmaceuticals、Amarin、Amgen、Amicus Therapeutics、Arbutus Biopharma、Arena Pharmaceuticals、Astellas Pharma、Atheronova、Biodel、BioMarin、Bionaturis、Biosidus、Biospherics、Boehringer Ingelheim、Bristol-Myers Squibb） ・糖尿病治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.The report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this market in the coming years. With the recent years witnessing an increase in number of people diagnosed with type 1 diabetes, there has been considerable increase in the adoption of insulin delivery systems. Focusing on skipping the need to schedule appointments and reduce expenses for clinical visits, increases the adoption of insulin delivery systems, where individuals use insulin injections at home under the guidance of a physician. This led to the introduction of insulin pens, pumps, and jet injectors, which, in turn, will drive the growth of the diabetic therapeutics market.
Characterized by the presence of numerous small and large-scale vendors, the diabetes treatment market appears to be highly competitive. The market is dominated by the major players such as AstraZeneca, Novo Nordisk, Merck, Eli Lilly, and Sanofi who are competing against each other to lead the market. The market also consists of a number of local manufacturers in various countries and will also witness the entry of several new players, which will further intensify the level of competition in the market. To increase their revenue shares and improve market position, vendors are focusing on strategic alliances which will help them in marketing and manufacturing drugs.
In terms of geographical regions, the Americas will be the major revenue contributor to the diabetic therapeutics market throughout the predicted period. The increasing prevalence of diabetes in countries such as the US, which provides opportunities for vendors to develop new, more efficient, and safer drugs will be the major factor driving market growth in this segment.
In 2018, the global Diabetic Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Diabetic Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Therapeutic development in United States, Europe and China.
The key players covered in this study
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
Amgen
Amicus Therapeutics
Arbutus Biopharma
Arena Pharmaceuticals
Astellas Pharma
Atheronova
Biodel
BioMarin
Bionaturis
Biosidus
Biospherics
Boehringer Ingelheim
Bristol-Myers Squibb
Market segment by Type, the product can be split into
Type 1
Type 2
Gestational
Market segment by Application, split into
Insulin therapies
Non-insulin therapies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Diabetic Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Diabetic Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Type 1
1.4.3 Type 2
1.4.4 Gestational
1.5 Market by Application
1.5.1 Global Diabetic Therapeutic Market Share by Application (2014-2025)
1.5.2 Insulin therapies
1.5.3 Non-insulin therapies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Diabetic Therapeutic Market Size
2.2 Diabetic Therapeutic Growth Trends by Regions
2.2.1 Diabetic Therapeutic Market Size by Regions (2014-2025)
2.2.2 Diabetic Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Diabetic Therapeutic Market Size by Manufacturers
3.1.1 Global Diabetic Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Therapeutic Key Players Head office and Area Served
3.3 Key Players Diabetic Therapeutic Product/Solution/Service
3.4 Date of Enter into Diabetic Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Diabetic Therapeutic Market Size by Type (2014-2019)
4.2 Global Diabetic Therapeutic Market Size by Application (2014-2019)
5 United States
5.1 United States Diabetic Therapeutic Market Size (2014-2019)
5.2 Diabetic Therapeutic Key Players in United States
5.3 United States Diabetic Therapeutic Market Size by Type
5.4 United States Diabetic Therapeutic Market Size by Application
6 Europe
6.1 Europe Diabetic Therapeutic Market Size (2014-2019)
6.2 Diabetic Therapeutic Key Players in Europe
6.3 Europe Diabetic Therapeutic Market Size by Type
6.4 Europe Diabetic Therapeutic Market Size by Application
7 China
7.1 China Diabetic Therapeutic Market Size (2014-2019)
7.2 Diabetic Therapeutic Key Players in China
7.3 China Diabetic Therapeutic Market Size by Type
7.4 China Diabetic Therapeutic Market Size by Application
8 Japan
8.1 Japan Diabetic Therapeutic Market Size (2014-2019)
8.2 Diabetic Therapeutic Key Players in Japan
8.3 Japan Diabetic Therapeutic Market Size by Type
8.4 Japan Diabetic Therapeutic Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Diabetic Therapeutic Market Size (2014-2019)
9.2 Diabetic Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Therapeutic Market Size by Type
9.4 Southeast Asia Diabetic Therapeutic Market Size by Application
10 India
10.1 India Diabetic Therapeutic Market Size (2014-2019)
10.2 Diabetic Therapeutic Key Players in India
10.3 India Diabetic Therapeutic Market Size by Type
10.4 India Diabetic Therapeutic Market Size by Application
11 Central & South America
11.1 Central & South America Diabetic Therapeutic Market Size (2014-2019)
11.2 Diabetic Therapeutic Key Players in Central & South America
11.3 Central & South America Diabetic Therapeutic Market Size by Type
11.4 Central & South America Diabetic Therapeutic Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Therapeutic Introduction
12.1.4 AstraZeneca Revenue in Diabetic Therapeutic Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Therapeutic Introduction
12.2.4 Eli Lilly Revenue in Diabetic Therapeutic Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Therapeutic Introduction
12.3.4 Merck Revenue in Diabetic Therapeutic Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Therapeutic Introduction
12.4.4 Novo Nordisk Revenue in Diabetic Therapeutic Business (2014-2019)
12.4.5 Novo Nordisk Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Therapeutic Introduction
12.5.4 Sanofi Revenue in Diabetic Therapeutic Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Therapeutic Introduction
12.6.4 AbbVie Revenue in Diabetic Therapeutic Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Actelion Pharmaceuticals
12.7.1 Actelion Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Therapeutic Introduction
12.7.4 Actelion Pharmaceuticals Revenue in Diabetic Therapeutic Business (2014-2019)
12.7.5 Actelion Pharmaceuticals Recent Development
12.8 Adocia
12.8.1 Adocia Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Therapeutic Introduction
12.8.4 Adocia Revenue in Diabetic Therapeutic Business (2014-2019)
12.8.5 Adocia Recent Development
12.9 Aegerion Pharmaceuticals
12.9.1 Aegerion Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Therapeutic Introduction
12.9.4 Aegerion Pharmaceuticals Revenue in Diabetic Therapeutic Business (2014-2019)
12.9.5 Aegerion Pharmaceuticals Recent Development
12.10 Akros Pharma
12.10.1 Akros Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Therapeutic Introduction
12.10.4 Akros Pharma Revenue in Diabetic Therapeutic Business (2014-2019)
12.10.5 Akros Pharma Recent Development
12.11 Alnylam Pharmaceuticals
12.12 Amarin
12.13 Amgen
12.14 Amicus Therapeutics
12.15 Arbutus Biopharma
12.16 Arena Pharmaceuticals
12.17 Astellas Pharma
12.18 Atheronova
12.19 Biodel
12.20 BioMarin
12.21 Bionaturis
12.22 Biosidus
12.23 Biospherics
12.24 Boehringer Ingelheim
12.25 Bristol-Myers Squibb
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Diabetic Therapeutic Key Market Segments
Table Key Players Diabetic Therapeutic Covered
Table Global Diabetic Therapeutic Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Therapeutic Market Size Market Share by Type 2014-2025
Figure Type 1 Figures
Table Key Players of Type 1
Figure Type 2 Figures
Table Key Players of Type 2
Figure Gestational Figures
Table Key Players of Gestational
Table Global Diabetic Therapeutic Market Size Growth by Application 2014-2025 (Million US$)
Figure Insulin therapies Case Studies
Figure Non-insulin therapies Case Studies
Figure Diabetic Therapeutic Report Years Considered
Table Global Diabetic Therapeutic Market Size 2014-2025 (Million US$)
Figure Global Diabetic Therapeutic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Therapeutic Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Therapeutic Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Therapeutic Market Share by Regions 2014-2019
Figure Global Diabetic Therapeutic Market Share by Regions 2014-2019
Figure Global Diabetic Therapeutic Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Therapeutic Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Therapeutic Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Therapeutic Market Share by Manufacturers in 2018
Table Global Diabetic Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Therapeutic Product/Solution/Service
Table Date of Enter into Diabetic Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Therapeutic Market Size Share by Type (2014-2019)
Figure Global Diabetic Therapeutic Market Size Market Share by Type (2014-2019)
Table Global Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Therapeutic Market Size Share by Application (2014-2019)
Figure Global Diabetic Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Therapeutic Revenue Market Share by Application in 2018
Figure United States Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Therapeutic Market Share (2018-2019)
Table United States Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Therapeutic Market Share by Type (2014-2019)
Table United States Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Therapeutic Market Share by Application (2014-2019)
Figure Europe Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Therapeutic Market Share (2018-2019)
Table Europe Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Therapeutic Market Share by Type (2014-2019)
Table Europe Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Therapeutic Market Share by Application (2014-2019)
Figure China Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Therapeutic Market Share (2018-2019)
Table China Diabetic Therapeutic Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Therapeutic Market Share by Type (2014-2019)
Table China Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Therapeutic Market Share by Application (2014-2019)
Figure Japan Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Therapeutic Market Share (2018-2019)
Table Japan Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Therapeutic Market Share by Type (2014-2019)
Table Japan Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Therapeutic Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Therapeutic Market Share (2018-2019)
Table Southeast Asia Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Therapeutic Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Therapeutic Market Share by Application (2014-2019)
Figure India Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Therapeutic Market Share (2018-2019)
Table India Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Therapeutic Market Share by Type (2014-2019)
Table India Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Therapeutic Market Share by Application (2014-2019)
Figure Central & South America Diabetic Therapeutic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Therapeutic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Therapeutic Market Share (2018-2019)
Table Central & South America Diabetic Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Therapeutic Market Share by Type (2014-2019)
Table Central & South America Diabetic Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Therapeutic Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Diabetic Therapeutic Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Eli Lilly Recent Development
Table Merck Company Details
Table Merck Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Merck Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Sanofi Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table AbbVie Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Actelion Pharmaceuticals Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Actelion Pharmaceuticals Recent Development
Table Adocia Company Details
Table Adocia Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Adocia Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Adocia Recent Development
Table Aegerion Pharmaceuticals Company Details
Table Aegerion Pharmaceuticals Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Aegerion Pharmaceuticals Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Aegerion Pharmaceuticals Recent Development
Table Akros Pharma Company Details
Table Akros Pharma Revenue in Diabetic Therapeutic Business (2014-2019)(Million US$)
Figure Akros Pharma Revenue Growth Rate in Diabetic Therapeutic Business (2014-2019)
Table Akros Pharma Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Amarin Company Details
Table Amgen Company Details
Table Amicus Therapeutics Company Details
Table Arbutus Biopharma Company Details
Table Arena Pharmaceuticals Company Details
Table Astellas Pharma Company Details
Table Atheronova Company Details
Table Biodel Company Details
Table BioMarin Company Details
Table Bionaturis Company Details
Table Biosidus Company Details
Table Biospherics Company Details
Table Boehringer Ingelheim Company Details
Table Bristol-Myers Squibb Company Details
Table Global Diabetic Therapeutic Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Therapeutic Market Size Share by Regions (2019-2025)
Figure Global Diabetic Therapeutic Market Size Share by Regions in 2025
Figure United States Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Therapeutic Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Therapeutic Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Therapeutic Market Size by Product (2019-2025)
Figure Global Diabetic Therapeutic Market Size by Product in 2025
Table Global Diabetic Therapeutic Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Therapeutic Market Size by Application (2019-2025)
Figure Global Diabetic Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
糖尿病治療の世界市場：市場規模・現状・予測 Diabetes is a chronic progressive disease characterized by hyperglycemia and glycosuria.Persistent high blood sugar can lead to many complications, such as retinal, kidney, nervous system and vascular complications.With the deepening of the basic theory of diabetes and the progress of molecular biol…- 糖尿病性神経障害の治療の世界市場：市場規模・現状・予測 Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage.Although there is no cure for diabet…
- デジタル治療機器の世界市場：市場規模・現状・予測 Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological conditionIn 2018, the global Digital Therapeutic Devices market size was xx million US$ and it is expected to…
- 黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 糖尿病性網膜症の治療の世界市場：市場規模・現状・予測 Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).In 2018, the global Diabetic Retinopathy Treatment market size was xx million US$ and it is e…